atlantic canada’s value proposition re$earch money conference november, 2007 halifax, nova scotia
TRANSCRIPT
Atlantic Canada’s Value Proposition
Re$earch Money Conference
November, 2007
Halifax, Nova Scotia
Atlantic Canada’s Value Proposition
Context to remarks• Understanding BioVectra Inc. and Diagnostic
Chemicals Limited• Our in-house research capabilities and focus• Our collaborations with Atlantic Canada
researchers and organizations• Our collaborations with Pharmaceutical and
Diagnostic companies
• Founded in 1970 by Dr. Regis Duffy
• Privately held and controlled
• DCL employs over 240 people in 3 countries
• Four manufacturing facilities plus administration headquarters in Canada; sales and distribution offices in the United States and Mexico
• Develops, manufactures and markets products worldwide
DCLandBioVectra
Prince Edward Island, Canada
• Manufacturing / Packaging
• Administration
• Research and Development
• Quality Control
• Regulatory Affairs
• Technical Services
Oxford, Connecticut
• Customer Services and Warehousing
• Field Sales and Technical Services
Mexico City, Mexico
• Customer Services and Warehousing
• Sales and Field Technical Services
DCL and BioVectra
Corporate OverviewRevenue 2003-2007
0
5,000
10,000
15,000
20,000
25,000
30,000
35,000
40,000
2003 2004 2005 2006 2007
Revenue
DCL and BioVectraActual and Projected
Revenue
0
10000
20000
30000
40000
50000
60000
2003 2004 2005 2006 2007 2008 2009
Revenue
Develops, manufactures and markets worldwide:
• Chemistry reagents for human and veterinary diagnostics
• Specialty / Niche chemistry reagents for human and veterinary diagnostics
• Immunochromatographic point-of-care assays
• Laboratory consumable manufacturing on a contract basis
Diagnostics
Provides services in:
• Contract Sales and Distribution
• Custom product formulations/manufacturing
• Lyophilization, dry and liquid blending
• Full kitting including dispensing and labeling
• Applications development / FDA filing
Diagnostics Strategy
R & D: External Collaboration
• Diagnostic companies with problem chemistries
• Universities with technologies in clinical chemistry
• Small firms or individuals with unique chemistries
Internal Activities• focus on product development
Diagnostics – keys to success
Focus on Manufacturing Excellence Unique Products Customer Service Human capital
A very good fit with Genzyme Corporation
• BioVectra is a cGMP manufacturer of APIs and advanced intermediates
• Fermentation• Bioextractions and purifications• PEG reagents & PEGylation services• Specialty biochemicals and
enzymes• Creating partnerships with others
utilizing our applied technologies to improve or enhance new and existing products
BioVectra
R & D: External collaboration
• Pharma and Biotech companies with unique problems
• Universities• NRC-INH• Drug discovery companies
BioVectra
R & D: Internal Activities
• PEGs ( a product used as part of the drug, to extend stability and improve performance )
• Taxanes – to gain an advantage in generic introduction of a semi-synthetic version of a major oncology drug
• New Drug Development program – a structure to invest in development of selected candidates
BioVectraKeys to Success:
• Focus on Manufacturing Excellence
• Unique Products• Customer Service• Human Capital
Atlantic Canada’s Value Proposition
North American strategic location
Good cost base for technical activities and manufacturing
Quality of life for employees is appreciated and creates loyalty
Low bureaucracy, ‘can-do’ attitude
Excellent public support climate Institutional support - NRC,
AVC, Universities
Atlantic Canada Value Proposition
Strong support and collaborative system in place; example - PEI BioAlliance
Canadian Business 2007 ranked Charlottetown as the 2nd best place to do business in Canada
Provincial Tax Incentives – Corporate tax, HR Recruitment support
ACOA Atlantic Innovation Fund (AIF) reduces product development risks
Some challenges
Experience base is limited among available labor Challenging to retain young mobile talent Must overcome perceptions of remote location – access
is an issue Removed from financial sources typically used by
competition
Atlantic Canada’s Value Proposition
Atlantic Canada can contribute to the national science and business goals
Think about it;• Strong university
environment• Well educated work force• Strong work ethic• Entrepreneurial spirit• Local government willing to
support economic innovation
Atlantic Canada’s Value Proposition
Some comments: Message to Governments –
“Atlantic Canada is stepping up” as a serious business contender in the science area
ACOA- AIF is an important tool for technology transfer and commercialization
Maintain and improve competitive tax incentives for science based businesses
Develop policies and incentives to attract world-class researchers and highly qualified personnel
Invest more in infrastructure and less on strategic forms
Atlantic Canada’s Value Proposition
This sector is an opportunity for Atlantic Canada to shine – We are committed to making this happen